Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 StudyLuis Paz‐Ares, C. Chouaïd, Óscar Juan et al.|Journal of Clinical Oncology|2024Cited by 126
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)Suresh S. Ramalingam, Claude El Kouri, Jeffrey Crawford et al.|Annals of Oncology|2013Cited by 57
Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferencesErin Moth, Prunella Blinman, Belinda E. Kiely et al.|Journal of Geriatric Oncology|2019Cited by 17
Novel treatments for novel side effects: a case report and review of baricitinib use in the treatment of chronic inflammatory demyelinating polyneuropathy caused by immune checkpoint inhibitor useSana Haider, Karuna Keat, Wei Chua et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 3
Older adults’ preferred and perceived roles in decision making about palliative chemotherapy: Their decision priorities, and information preferences.Erin Moth, Prunella Blinman, Belinda E. Kiely et al.|Journal of Clinical Oncology|2019Cited by 2